XI'AN, CHINA--(Marketwire - March 11, 2010) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced it has retained Grayling to provide the Company with financial communications support for its global investor relations program.